EU legislation genetically modified microbial biocontrol agents is fit for purpose EU legislative instruments are sufficient to ensure the safety of such products.
Surveillance and developments National Immunisation Programme 2015-2016 The report provides an overview of effectiveness and safety of vaccines and vaccine research.
RIVM starts field research into rubber granulate RIVM has started to take samples of rubber granulate from 100 synthetic turf fields in the Netherlands.
Need for strategy to assess endocrine disrupting chemicals There is a need for a strategy to enable companies and governments to assess whether chemicals are endocrine disrupting.
Ebola information for GPs RIVM has sent a message to Community Health Services (GGD's) containing information about how issues concerning Ebola are arranged in the Netherlands.
Possibly more cases of gastroenteritis caused by antacids In recent years the Netherlands has witnessed an increase in the number of cases of gastroenteritis caused by the Campylobacter bacterium.
Annual report RIVM 2013 online In our annual report, we look back at compelling RIVM projects and research in 2013.
Ongoing Ebola outbreak West Africa August 8th the World Health Organization declared the Ebola outbreak in West Africa an international health emergency and appealed for global aid to help afflicted countries.
RIVM involvement in UN/EU missions RIVM-experts from the Environmental Assessment Unit (EAU) have undertaken two missions involving an emergency situation in the Solomon Islands and an environmental assessment in Georgia.
Clinical condition Dutch MERS patients improving The two patients who were diagnosed last week with the MERS coronavirus are now on the mend.